Hospital-associated venous thromboembolisms (VTE), including pulmonary emboli, are the most common causes of preventable hospital death. Between ages 50 and 80, the mortality rate for pulmonary embolism more than doubles. Alongside severe mortality rates, VTE can cause long-term, chronic morbidities and many patients may suffer a recurrent event within 10 years after the initial diagnosis.
The risk for VTE is nearly universal among inpatients. Fortunately, pharmacologic and mechanical methods to prevent VTE are safe, cost-effective and supported by evidence-based research. Use same format as above - define VTE, then what are we doing to address it (PER MC EDITS)
Goal: By September 27, 2018, a 20 percent reduction in Venous Thromboembolism Events